Literature DB >> 33030639

Effects of feeding condition on the myocardial and hepatic accumulation of radioiodine-labeled BMIPP in mice.

Kazuaki Yamasaki1,2, Songji Zhao1, Mie Nishimura3, Yoichi Shimizu4, Nagara Tamaki1, Hiroshi Takeda3, Yuji Kuge5,6.   

Abstract

OBJECTIVE: 123I-15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid ([123I]BMIPP), a fatty acid analog, is widely used for the diagnosis of cardiac diseases. Feeding condition is one of the important factors in the myocardial fatty acid uptake, which may also affect myocardial accumulation of [123I]BMIPP and image quality of [123I]BMIPP scintigraphy. However, the relationship between the myocardial accumulation of [123I]BMIPP and the feeding condition is not entirely clear. Therefore, we determined the myocardial accumulation of [125I]BMIPP in mice at various metabolic statuses induced by fasting in comparison with the hepatic accumulation.
METHODS: Fed or fasted (6-, 12-, and 24-h fasted) mice were intravenously injected with [125I]BMIPP (35.2-75.0 kBq, 4 nmol). Radioactivities in the heart and liver were measured at 1, 5, 10, 30, 60, and 120 min after the injection (n = 5-15/time point for each group), and then, the heart-to-liver (H/L) ratios were calculated.
RESULTS: The myocardial accumulation level of [125I]BMIPP in the fed group was almost the same as that in the 6-h-fasted group at each time point, although it was decreased by 12- and 24-h fasting. The H/L ratios of [125I]BMIPP accumulation level were significantly decreased by fasting (1.92 ± 0.22, 1.45 ± 0.13, 1.12 ± 0.13, and 0.91 ± 0.15 at 10 min, and 3.30 ± 0.62, 2.09 ± 0.35, 1.79 ± 0.34, and 1.27 ± 0.06 at 30 min after the injection, respectively, for the fed group and the 6-, 12-, and 24-h-fasted groups; p < 0.0001), largely owing to the increase in the hepatic accumulation level in the fasting groups.
CONCLUSION: Although short-period (6 h) fasting did not affect the myocardial accumulation level of [125I]BMIPP, the hepatic accumulation level was increased. The present results indicate that the fed condition may provide higher-contrast images in myocardial [123I]BMIPP scintigraphy.

Entities:  

Keywords:  Cardiology; Nuclear imaging; [123/125I]BMIPP

Year:  2020        PMID: 33030639     DOI: 10.1007/s12149-020-01535-x

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  5 in total

1.  Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP.

Authors:  C Kurata; Y Wakabayashi; S Shouda; T Mikami; Y Takei; K Tawarahara; T Sugiyama; T Nakano; S Fujisawa; A Andoh
Journal:  J Nucl Med       Date:  1997-07       Impact factor: 10.057

2.  Irbesartan attenuates atherosclerosis in Watanabe heritable hyperlipidemic rabbits: noninvasive imaging of inflammation by 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Yan Zhao; Keita Fukao; Songji Zhao; Ayahisa Watanabe; Tadateru Hamada; Kazuaki Yamasaki; Yoichi Shimizu; Naoki Kubo; Naoyuki Ukon; Toru Nakano; Nagara Tamaki; Yuji Kuge
Journal:  Mol Imaging       Date:  2015       Impact factor: 4.488

3.  Myocardial metabolism of 123I-BMIPP in a canine model with ischemia: implications of perfusion-metabolism mismatch on SPECT images in patients with ischemic heart disease.

Authors:  R Hosokawa; R Nohara; Y Fujibayashi; K Okuda; M Ogino; T Hirai; M Fujita; N Tamaki; J Konishi; S Sasayama
Journal:  J Nucl Med       Date:  1999-03       Impact factor: 10.057

4.  Effect of oral glucose loading on the biodistribution of BMIPP in normal volunteers.

Authors:  F De Geeter; V Caveliers; I Pansar; A Bossuyt; P R Franken
Journal:  J Nucl Med       Date:  1998-11       Impact factor: 10.057

5.  Effect of metabolic substrate on BMIPP metabolism in canine myocardium.

Authors:  R Nohara; R Hosokawa; T Hirai; K Okuda; M Ogino; Y Fujibayashi; M Fujita; S Sasayama
Journal:  J Nucl Med       Date:  1998-07       Impact factor: 10.057

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.